Germany Tuberculosis Diagnosis and Treatment Market Trends Adopted by the Competitors, Regions with Forecast by 2025

Germany tuberculosis diagnosis and treatment market is anticipated to grow at a CAGR around 3.0% during the forecast period. Germany is significant market has been one of the significant market in the European tuberculosis diagnostic and treatment market. In 2018, a total of 5,429 tuberculosis (TB) cases were notified in Germany. The number of total cases remained almost unchanged in comparison to the 2015 which was 5,828 cases and incidence of 7.1. According to the Robert Koch institute, the tuberculosis incidence in foreign nationals residing in Germany was 19 times higher than the incidence in German citizens. This difference between the two groups increased in comparison to the previous year (16.6 times higher). The largest difference was observed in young adults. Overall, Germans comprised of 30.9 % of all tuberculosis cases, whereas the remaining 69.1 % of all cases were foreign nationals. Foreign nationals affected by tuberculosis were younger than German nationals.

Get Sample Copy of Germany Tuberculosis Diagnosis and Treatment Market at: https://www.omrglobal.com/request-sample/germany-tuberculosis-diagnosis-treatment-market

The key players that are active in the market include Abbott Laboratories, Becton, Dickinson and Co., F. HOFFMANN-LA ROCHE LTD., GlaxoSmithKline PLC, Hain Lifescience GmbH, Johnson & Johnson, OTSUKA NOVEL PRODUCTS GMBH, Pifzer, Inc., Qiagen GMBH and Sandoz Inc.

The German TB-surveillance system is essential for timely identification of epidemiological trends and their interpretation in the context of factors that potentially influence the epidemiological situation. Rising case numbers in the non-German population, multidrug-resistant and extensively drug-resistant TB, and a high proportion of infectious pulmonary TB indicate that TB remains a significant public health issue in Germany, with an increasing burden among high risk groups.

For More Information, get A full report of Germany Tuberculosis Diagnosis and Treatment Market is available at: https://www.omrglobal.com/industry-reports/germany-tuberculosis-diagnosis-treatment-market

Germany tuberculosis diagnosis and treatment market is segmented on the basis of drugs type and diagnosis. Based on drug type, the market is segmented into first line drugs and second line drugs. Based on diagnosis, the market is segmented into laboratory testing, nucleic acid amplification test, mantoux test, radiography and drug susceptibility testing.

The market players are considerably contributing to the market growth by the adoption of various strategies including new product launch, merger, and acquisition, collaborations with government, funding to the start-ups and technological advancements to stay competitive in the market.

Market Segmentation

Tuberculosis Diagnosis and Treatment Market by Drugs Type

o First Line Drugs
o Second Line Drugs

Tuberculosis Diagnosis and Treatment Market by Diagnosis

o Laboratory Testing
o Nucleic Acid Amplification Test
o Mantoux Test
o Radiography
o Drug Susceptibility Testing

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/germany-tuberculosis-diagnosis-treatment-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.